title: Rising drug costs: the impact on dermatology.
abstract: In the US prescription drug costs are rising faster than any other component of health care expenditures, and show no signs of slowing. Spending on prescription drugs has been estimated by the Health Care Finance Administration (HCFA) to be rising by approximately 12% per year, more than twice the rate for national health care expenditures (5.1%). Factors driving the rise in prescription drug costs include the introduction of new drugs, and consumer demand.
authors.affiliation: New York University School of Medicine, New York, New York, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Rico
mesh_terms: D003363:Cost Control; D003365:Costs and Cost Analysis; D003879:Dermatologic Agents / Q000191:economics*; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement; D012871:Skin Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D003879:Dermatologic Agents; D016568:Drugs, Generic